MP-facing HTML Brief

Florida Renu Daily Creative Draft — 2026-07-25

Florida Renu Daily Creative Draft — 2026-07-25

Status: Needs MP Approval — draft only

Approval Summary

  • Proposed channels: Instagram Feed, Instagram Story, Facebook, Google Business Profile
  • Decision needed: approve, revise, or reject the concept, copy, and visual direction
  • Publishing/scheduling: not attempted

Strategic Intent

  • Pillar: Semaglutide / GLP-1
  • Content job: Education / trust building
  • Funnel stage: Awareness / consideration
  • Target patient or question: Florida Renu prospective patient
  • Single takeaway: Medical weight-loss support works best with monitoring, habits, and realistic expectations.
  • Why today: Selected by the daily content rotation
  • Originality note: Review against recent content before approval

Creative Concept

  • Format: Myth / Fact Card
  • Hook: GLP-1s Are A Tool — Not The Whole Plan
  • Supporting message: Medical weight-loss support works best with monitoring, habits, and realistic expectations.
  • CTA: Schedule an evaluation to see what’s appropriate for you.
  • Tone: Calm, credible, approachable
  • Asset type: Legacy deterministic SVG service-benefit card (fallback renderer; no production.feedFinalAsset/storyFinalAsset supplied)

Reference Infusion

  • Primary reference: Florida Renu approved Instagram reference set
  • Secondary reference: Florida Renu brand guide
  • Traits borrowed: blue/white hierarchy; organic photo crop; short mobile-readable copy
  • Avoided: pixel-for-pixel copying; unverified claims; logo recreation

Exact On-Image Copy

  • Pillar tag: SEMAGLUTIDE / GLP-1
  • Headline: GLP-1s Are A Tool — Not The Whole Plan
  • Support: Medical weight-loss support works best with monitoring, habits, and realistic expectations.

Caption Draft

Semaglutide and GLP-1 support are medical tools — not magic. A safe plan should include provider guidance, progress tracking, and lifestyle support.

Save this before starting any weight-loss medication.

Schedule an evaluation to see what’s appropriate for you.

#GLP1 #Semaglutide #MedicalWeightLoss #FloridaRenu

Production Direction

  • Photography: Professional, realistic South Florida medical-wellness imagery relevant to the service
  • Composition: Reference-led split layout with an organic photo crop and strong blue/white hierarchy
  • Feed prompt: Use the selected Florida Renu references as art-direction inputs while preserving the exact logo and supplied copy.
  • Story prompt: Recompose vertically; keep the full message above platform UI safe zones rather than merely cropping the Feed asset.
  • Shared negative prompt: No fake testimonials, invented clinic features, distorted hands/equipment, altered logo, clipped text, or miracle-result imagery.

Medical / Compliance Review

  • Claim basis: General educational language; provider evaluation and individual suitability apply
  • Required qualification: Educational content only; treatment suitability varies by patient
  • Prohibited wording checked: Requires review

Creative Preview

![Feed creative](/home/mpier/.openclaw/workspace/projects/florida-renu-content/content-queue/daily-creative/2026-07-25/2026-07-25-semaglutide-glp-1-feed-draft.png)

![Story creative](/home/mpier/.openclaw/workspace/projects/florida-renu-content/content-queue/daily-creative/2026-07-25/2026-07-25-semaglutide-glp-1-story-draft.png)

Assets

  • Feed asset: /home/mpier/.openclaw/workspace/projects/florida-renu-content/content-queue/daily-creative/2026-07-25/2026-07-25-semaglutide-glp-1-feed-draft.png
  • Feed SVG source: /home/mpier/.openclaw/workspace/projects/florida-renu-content/content-queue/daily-creative/2026-07-25/2026-07-25-semaglutide-glp-1-feed-draft.svg
  • Story asset: /home/mpier/.openclaw/workspace/projects/florida-renu-content/content-queue/daily-creative/2026-07-25/2026-07-25-semaglutide-glp-1-story-draft.png
  • Story SVG source: /home/mpier/.openclaw/workspace/projects/florida-renu-content/content-queue/daily-creative/2026-07-25/2026-07-25-semaglutide-glp-1-story-draft.svg
  • Feed dimensions: 1080x1080 (4:5 target)
  • Story dimensions: 1080x1920 (9:16 target)
  • Prompt brief JSON: legacy deterministic topic fallback
  • Dry-run payload: /home/mpier/.openclaw/workspace/projects/florida-renu-content/content-queue/daily-creative/2026-07-25/2026-07-25-semaglutide-glp-1-ghl-dry-run-payload.json

QA Gate

  • Draft-only; no social scheduling/publishing attempted
  • Logo fidelity visually compared against the exact supplied asset
  • On-image copy checked letter by letter
  • Florida Renu naming verified
  • No clipped or overlapping text
  • Feed and Story inspected for mobile readability
  • Florida Renu blue/white color direction verified
  • No distorted anatomy or equipment
  • No false or unsupported claims
  • Reference grounding visually evident
  • Feed and Story are distinct prompt-native compositions
  • Feed file generated at 1080x1080; Story at 1080x1920
  • GHL payload remains dry-run only
  • QA status: not recorded
  • QA notes: Visual inspection has not been recorded.

Final MP approval is still required. No social or GHL publishing/scheduling has occurred.

Creative Preview

Feed
2026-07-25-semaglutide-glp-1-feed-draft.png
2026-07-25-semaglutide-glp-1-feed-draft.png
Story
2026-07-25-semaglutide-glp-1-story-draft.png
2026-07-25-semaglutide-glp-1-story-draft.png